Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gateway Associates was a venture capital firm based in St. Louis, Missouri, that specialized in early-stage investments within the life sciences, biotechnology, and high-technology sectors. Active primarily during the 1990s and early 2000s, the firm played a significant role in the development of the St. Louis biotechnology corridor by funding emerging companies such as North American Vaccine and Kereos. The firm was led by prominent industry figures including Jeffrey Spragens and Constantine Anagnostopoulos, who later went on to lead major biopharmaceutical organizations. Gateway Associates focused on leveraging regional academic and research excellence to commercialize promising medical and scientific technologies. While the firm is no longer active in making new investments, its legacy persists through the successful companies and leadership it helped establish in the healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gateway Associates.